skip to main content

H.R. 1553 (110th): Caroline Pryce Walker Conquer Childhood Cancer Act of 2008

The text of the bill below is as of Mar 15, 2007 (Introduced).



1st Session

H. R. 1553


March 15, 2007

(for herself, Mr. Van Hollen, Mr. McCaul of Texas, Mr. Sestak, Mr. Ferguson, Mr. Castle, Mr. Yarmuth, Mr. Reichert, Mr. Hastings of Florida, Mr. Schiff, Mr. Mica, Mr. Ruppersberger, Mrs. Musgrave, Mr. Larsen of Washington, Mr. Graves, Mr. Platts, Mr. Culberson, Mr. Engel, Mr. Higgins, Mr. Boucher, Mr. Moran of Virginia, Mr. Reyes, Mr. Kildee, Mr. Dreier, Mr. Chandler, Mr. Sessions, Mr. Grijalva, Mr. Shuster, Mr. Al Green of Texas, and Mr. Forbes) introduced the following bill; which was referred to the Committee on Energy and Commerce


To amend the Public Health Service Act to advance medical research and treatments into pediatric cancers, ensure patients and families have access to the current treatments and information regarding pediatric cancers, establish a population-based national childhood cancer database, and promote public awareness of pediatric cancers.


Short title

This Act may be cited as the Conquer Childhood Cancer Act of 2007.



Congress makes the following findings:


Cancer kills more children than any other disease.


Each year cancer kills more children between 1 and 20 years of age than asthma, diabetes, cystic fibrosis, and AIDS, combined.


Every year, over 12,500 young people are diagnosed with cancer.


Each year about 2,300 children and teenagers die from cancer.


One in every 330 Americans develops cancer before age 20.


Some forms of childhood cancer have proven to be so resistant that even in spite of the great research strides made, most of those children die. Up to 75 percent of the children with cancer can now be cured.


Brain tumors are now the most common cause of cancer-related death in children and are the most common solid tumor of childhood. Neuroblastoma is the second most common pediatric solid tumor (after brain tumors) and represents a major therapeutic challenge. More than 50 percent of children with metastatic disease still die despite aggressive, toxic chemotherapy regimens.


The causes of most childhood cancers are not yet known.


Childhood cancers are mostly those of the white blood cells (leukemias), brain, bone, the lymphatic system, and tumors of the muscles, kidneys, and nervous system. Each of these behaves differently, but all are characterized by an uncontrolled proliferation of abnormal cells.


Eighty percent of the children who are diagnosed with cancer have disease which has already spread to distant sites in the body.


Ninety percent of children with a form of pediatric cancer are treated at one of the more than 200 Children's Oncology Group member institutions throughout the United States.



It is the purpose of this Act to authorize appropriations to—


encourage and expand the support for biomedical research programs of the existing National Cancer Institute-designated multi-center national infrastructure for pediatric cancer research;


establish a population-based national childhood cancer database (the Children's Cancer Research Network) to evaluate incidence trends of childhood cancers and to enable the investigations of genetic epidemiology in order to identify causes to aid in development of prevention strategies;


provide informational services to patients and families affected by childhood cancer;


support the development, construction and operation of a comprehensive online public information system on childhood cancers and services available to families; and


establish a fellowship program in pediatric cancer research to foster clinical and translational research career development in pediatric oncologists in the early stages of their career.


Pediatric cancer research and awareness

Subpart 1 of part C of title IV of the Public Health Service Act (42 U.S.C. 285 et seq.) is amended by adding at the end thereof the following:


Pediatric cancer research and awareness


Pediatric cancer research


Special programs of research excellence in pediatric cancers

The Director of NIH, acting through the National Cancer Institute, shall establish special programs of research excellence in the area of pediatric cancers. Such programs shall demonstrate a balanced approach to research cause, prognosis, prevention, diagnosis, and treatment of pediatric cancers that foster translation of basic research findings into innovative interventions applied to patients.


Fellowship of excellence in pediatric cancer research

The Secretary shall develop a grant mechanism for the establishment, in cooperation with the National Cancer Institute-supported pediatric cancer clinical trial groups, of Research Fellowships in Pediatric Cancer to support adequate numbers of pediatric focused clinical and translational investigators thereby facilitating continuous momentum of research excellence.


National Childhood Cancer Registry

The Director of NIH shall award a grant for the operation of a population-based national childhood cancer database, the Childhood Cancer Research Network (CCRN), of the Children’s Oncology Group, in cooperation with the National Cancer Institute.


Public awareness of pediatric cancers and available treatments and research

The Secretary shall award grants to recognized childhood cancer professional and advocacy organizations for the expansion and widespread implementation of activities to raise public awareness of currently available information, treatment, and research with the intent to ensure access to best available therapies for pediatric cancers.


Authorization of appropriations

There is authorized to be appropriated to carry out this section $30,000,000 for each of fiscal years 2008 through 2012. Funds appropriated under this section shall remain available until expended.